These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 2146735
1. Cardiac ornithine decarboxylase of diabetic spontaneously hypertensive rat: effects of insulin and thyroid hormone treatment. Christe ME, Rodgers RL. Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):297-315. PubMed ID: 2146735 [Abstract] [Full Text] [Related]
5. Morphometrical and biochemical differences of endocrine pancreata between spontaneously hypertensive and normotensive rats with or without neonatal streptozotocin-induced diabetes. Iwase M, Nunoi K, Kikuchi M, Maki Y, Kodama T, Sadoshima S, Fujishima M. Lab Invest; 1989 Jan; 60(1):102-5. PubMed ID: 2521365 [Abstract] [Full Text] [Related]
6. Regional changes in ornithine decarboxylase activity and polyamine levels during thyroxine-induced cardiac hypertrophy. Tipnis UR, Skiera C. Cytobios; 1989 Jan; 57(229):101-8. PubMed ID: 2528442 [Abstract] [Full Text] [Related]
8. Effects of ovariectomy on indices of insulin resistance, hypertension, and cardiac energy metabolism in middle-aged spontaneously hypertensive rats (SHR). Swislocki A, Burgie ES, Rodnick KJ. Horm Metab Res; 2002 Sep; 34(9):516-22. PubMed ID: 12384829 [Abstract] [Full Text] [Related]
10. Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats. Wu L, Wang R, De Champlain J, Wilson TW. Am J Hypertens; 2004 Sep; 17(9):749-56. PubMed ID: 15363815 [Abstract] [Full Text] [Related]
11. Altered cardiac polyamine biosynthesis in spontaneously hypertensive rats. Ruskoaho H, Raunio H. Am J Physiol; 1987 Aug; 253(2 Pt 2):H262-9. PubMed ID: 2956895 [Abstract] [Full Text] [Related]
14. Effect of different thyroid state on ornithine decarboxylase activity and receptors of T3 in rat liver. Knopp J, Brtko J. Exp Clin Endocrinol; 1989 Aug; 94(3):319-23. PubMed ID: 2630312 [Abstract] [Full Text] [Related]
15. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes. Wold LE, Relling DP, Colligan PB, Scott GI, Hintz KK, Ren BH, Epstein PN, Ren J. J Mol Cell Cardiol; 2001 Sep; 33(9):1719-26. PubMed ID: 11549350 [Abstract] [Full Text] [Related]
16. Effect of hypertension on the development of diabetic cardiomyopathy. Mathis DR, Liu SS, Rodrigues BB, McNeill JH. Can J Physiol Pharmacol; 2000 Oct; 78(10):791-8. PubMed ID: 11077979 [Abstract] [Full Text] [Related]
17. Changes in plasma prekallikrein activity, blood pressure, and left ventricular thickness in hypertensive and normotensive diabetic rats. Sharma JN, Kesavarao U. Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):75-8. PubMed ID: 17440623 [Abstract] [Full Text] [Related]
18. Regression of left ventricular hypertrophy and control of hypertension in the spontaneously hypertensive rat (SHR): oxprenolol versus hydrochlorothiazide. Idikio H, Fernandez PG, Triggle CR, Kim BK. Clin Invest Med; 1983 Mar; 6(1):43-8. PubMed ID: 6219850 [Abstract] [Full Text] [Related]
19. Cardiac function of the diabetic renovascular hypertensive rat: effects of insulin and thyroid hormone treatment. Rodgers RL, Davidoff AJ, Mariani MJ. Can J Physiol Pharmacol; 1991 Mar; 69(3):346-54. PubMed ID: 2059900 [Abstract] [Full Text] [Related]
20. Role of thyroid hormone in the development of beta adrenergic control of ornithine decarboxylase in rat heart and kidney. Pracyk JB, Lappi SE, Slotkin TA. J Pharmacol Exp Ther; 1991 Feb; 256(2):757-66. PubMed ID: 1847210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]